Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biometrical Journal. Biometrische Zeitschrift|April 26, 2008
A relative survival model for clustered responsesOliver Kuss, Thomas Blankenburg, Johannes Haerting
The Clinical Respiratory Journal|July 25, 2012
Six-minute walk distance and dyspnoea scores to assess the course of COPD exacerbation in elderly patientsThomas Blankenburg, Anne Guettel, Christian Busch, et al.
Case Reports in Oncology|August 16, 2014
A Prospective Phase I/II Study: Combination Chemotherapy with Docetaxel and Pemetrexed as Second-Line Treatment in Patients with Stage IIIB/IV Non-Small Cell Lung CancerVinzenz Kroeber, Sylke Nagel, Wolfgang Schuette, et al.
Onkologie|April 21, 2005
Clinical benefit in NSCLC: advanced-stage patients require symptom-improving palliation. Experiences from the 'Iressa' expanded access programWolfgang Schütte, Sylke Nagel, Steffen Schaedlich, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 5, 2004
Survival of patients in clinical stages I-IIIb of non-small-cell lung cancer treated with radiation therapy alone. Results of a population-based study in Southern Saxony-AnhaltAnja Bollmann, Thomas Blankenburg, Johannes Haerting, et al.
Clinical Lung Cancer|September 24, 2005
Phase II trial of gemcitabine/irinotecan in refractory or relapsed small-cell lung cancerWolfgang Schuette, Sylke Nagel, Stefan Juergens, et al.
The Open Respiratory Medicine Journal|August 26, 2017
Survival of Hypercapnic Patients with COPD and Obesity Hypoventilation Syndrome Treated with High Intensity Non Invasive Ventilation in the Daily Routine CareThomas Blankenburg, Christin Benthin, Stefanie Pohl, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 5, 2010
Influence of NaCl 0.9% Infusion during Plasmapheresis on IgG Content in PlasmaJosef Evers, Jochen Betz, Thomas Blankenburg, et al.
Clinical Lung Cancer|November 12, 2003
A multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesotheliomaWolfgang Schutte, Thomas Blankenburg, Kathrin Lauerwald, et al.
Clinical Lung Cancer|April 28, 2006
Multicenter randomized trial for stage IIIB/IV non-small-cell lung cancer using every-3-week versus weekly paclitaxel/carboplatinWolfgang Schuette, Thomas Blankenburg, Wolf Guschall, et al.
Pageof 2